info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Seladelpar
521
Article source: Seagull Pharmacy
Oct 09, 2025

Seladelpar is a new-type therapeutic drug for primary biliary cholangitis (PBC), which exerts its effects by activating peroxisome proliferator-activated receptor delta (PPARδ).

Indications for Seladelpar

Main Therapeutic Uses

Seladelpar is approved for the treatment of two categories of adult patients with primary biliary cholangitis (PBC) as follows.

Combination therapy: Used in combination with ursodeoxycholic acid (UDCA), it is indicated for PBC patients with an inadequate response to UDCA.

Monotherapy: Used as monotherapy for PBC patients who cannot tolerate UDCA.

Usage Restrictions and Precautions

It is not recommended for patients with decompensated cirrhosis (e.g., ascites, variceal bleeding, hepatic encephalopathy).

It must be used under the guidance of a physician with experience in PBC treatment.

Regular monitoring of liver function indicators and bone health status is required.

Specifications and Properties of Seladelpar

Preparation Specifications

Seladelpar is an oral hard capsule preparation.

Specification: 10 mg per capsule (calculated as seladelpar free acid).

Appearance Characteristics

The capsules are opaque.

Size: Size 1 capsules.

Color: Opaque light gray capsule body and opaque dark blue capsule cap.

Marking: The capsule cap is printed with "CBAY", and the capsule body is printed with "10".

Composition

Active ingredient: 14.1 mg seladelpar lysine salt (equivalent to 10 mg seladelpar free acid).

Excipients: Butylated hydroxytoluene (BHT), colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, mannitol, microcrystalline cellulose.

Capsule shell: Gelatin, titanium dioxide, iron oxide colorants, and FD&C Blue No. 2.

Storage Method for Seladelpar

Storage Condition Requirements

Temperature: Store at room temperature between 20°C and 25°C (68°F and 77°F).

Allowable fluctuation range: Short-term exposure to temperatures between 15°C and 30°C (59°F and 86°F) is tolerable.

Precautions: Keep in the original packaging to protect from light and avoid humid environments.

Special Handling Requirements

Child protection: Packaged with child-resistant caps; store out of the reach of children.

Moisture and damage prevention: Keep the desiccant inside the bottle intact and avoid crushing or deforming the capsules.

Expired disposal: Expired drugs should be disposed of professionally in accordance with local regulations.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Use Seladelpar
Seladelpar is a peroxisome proliferator-activated receptor (PPAR)-δ agonist, which was approved in the United States in 2024 for the treatment of primary biliary cholangitis (PBC).How to Use Seladelpa...
Precautions for Seladelpar Administration
Seladelpar is a peroxisome proliferator-activated receptor (PPAR)-δ agonist. It is indicated for combination therapy with ursodeoxycholic acid (UDCA) in adult patients who have an inadequate response ...
What Are the Side Effects of Seladelpar?
Seladelpar is a peroxisome proliferator-activated receptor (PPAR)-δ agonist, primarily used for the treatment of adult patients with primary biliary cholangitis (PBC) who have an inadequate response t...
Indications for Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar)
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a compound antihypertensive medication composed of losartan potassium (an angiotensin II receptor blocker, ARB) and hydrochlorothiazide (...
How to Purchase Seladelpar
Seladelpar is a novel PPAR-δ agonist, indicated for the treatment of adult patients with primary biliary cholangitis (PBC) who have an inadequate response to ursodeoxycholic acid (UDCA) or cannot tole...
What Are the Side Effects of Opdualag?
Opdualag is a fixed-dose combination medication consisting of nivolumab and relatlimab-rmbw. It is indicated for the treatment of patients aged 12 years and older with unresectable or metastatic melan...
Precautions for Opdualag Administration
Opdualag is a fixed-dose combination preparation of nivolumab and relatlimab-rmbw, indicated for the treatment of patients aged 12 years and older with unresectable or metastatic melanoma.Precautions ...
How to Use Opdualag
Opdualag is a fixed-dose combination preparation composed of nivolumab and relatlimab-rmbw. It is indicated for the treatment of patients aged 12 years and older with unresectable or metastatic melano...
Related Articles
Contraindications and adverse reactions of itraconazole
Although eltrombopag has no absolute contraindications, it has clear warnings and potential serious adverse reactions. Understanding these risks is a prerequisite for safe medication use.I. Contraindi...
Special population medication of eltrombopag
The use of eltrombopag in special populations requires individualized adjustment. This article reviews key medication points around factors such as hepatic and renal function, age, and ethnicity.I. Do...
Precautions for healthy diet of patients with eltrombopag
When taking eltrombopag, diet directly affects drug absorption and efficacy. Mastering the correct dietary principles is an important part of ensuring safe and effective treatment.I. Timing of Medicat...
Contraindications and adverse reactions of Epclusa
Epclusa is generally well tolerated, but contraindications and adverse reactions require special attention when combined with ribavirin. The following explains from three aspects.I. Contraindications1...
Special population use of Epclusa
Epclusa requires no dosage adjustment in most special populations, but some populations require careful evaluation. The following explains three situations separately.I. Populations with Abnormal Live...
Precautions for healthy diet of patients with Epclusa
During treatment with Epclusa, there are no special dietary restrictions, but a reasonable diet can help reduce discomfort and ensure efficacy. The following explains from three aspects.I. Administrat...
Contraindications and Adverse Reactions of Capmatinib
Capmatinib is used for metastatic non-small cell lung cancer with a mutation that leads to MET exon 14 skipping. It has no absolute contraindications, but several adverse reactions require close monit...
Dietary precautions for patients with Capmatinib
Capmatinib may be taken with or without food, but dietary components, dosing habits, and concomitant medications can directly affect efficacy and safety. The following explains administration, dietary...
New Drugs
Cenobamate(Xcopri)
Cenobamate(Xcopri)
It is used for the treatment of partial-onset seizures in adults (with or...
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved